Recent work has identified mutations in SAMD9 in children with myelodysplasia, infection, restriction of growth, adrenal hypoplasia, genital phenotypes, and enteropathy, named MIRAGE syndrome (OMIM #617053) (Figs. 1b and 2; Table 1) [27]. This evidence concerns the gene SAMD9 and MIRAGE syndrome.